Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Department of Public Health and Caring Sciences, Molecular Geriatrics, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Fluids Barriers CNS. 2023 Oct 13;20(1):72. doi: 10.1186/s12987-023-00472-x.
Neuroinflammatory processes have been suggested to play a role in the pathophysiology of neurodegenerative diseases and post-hemorrhagic hydrocephalus, but have rarely been investigated in patients with idiopathic normal pressure hydrocephalus (iNPH). The aim of this study was to investigate whether levels of inflammatory proteins in CSF are different in iNPH compared to healthy controls and patients with selected neurodegenerative disorders, and whether any of these markers can aid in the differential diagnosis of iNPH.
Lumbar CSF was collected from 172 patients from a single center and represented iNPH (n = 74), Alzheimer's disease (AD) (n = 21), mild cognitive impairment (MCI) due to AD (n = 21), stable MCI (n = 22), frontotemporal dementia (n = 13), and healthy controls (HC) (n = 21). Levels of 92 inflammatory proteins were analyzed using a proximity extension assay. As a first step, differences between iNPH and HC were investigated, and proteins that differed between iNPH and HC were then compared with those from the other groups. The linear regressions were adjusted for age, sex, and plate number.
Three proteins showed higher (MCP-1, p = 0.0013; CCL4, p = 0.0008; CCL11, p = 0.0022) and one lower (PD-L1, p = 0.0051) levels in patients with iNPH compared to HC. MCP-1 was then found to be higher in iNPH than in all other groups. CCL4 was higher in iNPH than in all other groups, except in MCI due to AD. PD-L1 was lower in iNPH compared to all other groups, except in stable MCI. Levels of CCL11 did not differ between iNPH and the differential diagnoses. In a model based on the four proteins mentioned above, the mean area under the receiver operating characteristic curve used to discriminate between iNPH and the other disorders was 0.91.
The inflammatory cytokines MCP-1 and CCL4 are present at higher-and PD-L1 at lower-levels in iNPH than in the other investigated diagnoses. These three selected cytokines may have diagnostic potential in the work-up of patients with iNPH.
神经炎症过程被认为在神经退行性疾病和出血后脑积水的病理生理学中起作用,但在特发性正常压力脑积水(iNPH)患者中很少被研究。本研究的目的是探讨 iNPH 患者与健康对照组和选定神经退行性疾病患者的脑脊液(CSF)中炎症蛋白水平是否不同,以及这些标志物是否有助于 iNPH 的鉴别诊断。
从单中心收集了 172 名患者的腰椎 CSF,代表 iNPH(n=74)、阿尔茨海默病(AD)(n=21)、AD 引起的轻度认知障碍(MCI)(n=21)、稳定 MCI(n=22)、额颞叶痴呆(n=13)和健康对照组(HC)(n=21)。使用邻近延伸测定法分析了 92 种炎症蛋白的水平。作为第一步,研究了 iNPH 和 HC 之间的差异,然后将 iNPH 和 HC 之间存在差异的蛋白与其他组进行比较。线性回归根据年龄、性别和板数进行调整。
与 HC 相比,三种蛋白在 iNPH 患者中水平更高(MCP-1,p=0.0013;CCL4,p=0.0008;CCL11,p=0.0022),一种蛋白水平更低(PD-L1,p=0.0051)。然后发现 MCP-1 在 iNPH 患者中高于所有其他组。CCL4 在 iNPH 患者中的水平高于所有其他组,除了 AD 引起的 MCI。PD-L1 在 iNPH 患者中的水平低于所有其他组,除了稳定 MCI。CCL11 的水平在 iNPH 和鉴别诊断之间没有差异。在基于上述四种蛋白的模型中,用于区分 iNPH 和其他疾病的受试者工作特征曲线下的平均面积为 0.91。
与其他研究诊断相比,iNPH 患者中炎症细胞因子 MCP-1 和 CCL4 的水平更高,而 PD-L1 的水平更低。这三种选定的细胞因子可能在 iNPH 患者的评估中有诊断潜力。